Clinical Trial Update: MASTER I - Microvolt T Wave Alternans Testing for Risk Stratification of Post MI Patients [NA]

View source ↗

Summary

The MASTER I trial evaluating Microvolt T Wave Alternans testing for risk stratification in post-myocardial infarction patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ischemic Cardiomyopathy
• Myocardial Infarction
• Ventricular Arrhythmia

Snippet

Sponsor: Medtronic Cardiac Rhythm and Heart Failure | Conditions: Myocardial Infarction, Arrhythmia, Ventricular | NA | Status: COMPLETED